Plain-English translation of NCT05276219 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
When your heart suddenly can't pump well enough, fluid backs up into your lungs, making it hard to breathe. This trial compares three emergency treatment strategies: furosemide (a water pill given through an IV), (a medication that relaxes blood vessels), or both medications together. Doctors want to know which approach works best to help you breathe easier and feel better quickly.
Right now, guidelines recommend using the water pill as the main treatment, but no one has tested whether combining it with the blood vessel relaxer works even better. This trial will help doctors figure out the best emergency treatment strategy for this life-threatening situation.
You likely qualify if…
You likely don't qualify if…
When you arrive at the hospital in respiratory distress, you'll be randomly assigned to receive one of three treatment strategies through an IV line during your first 6 hours of care. Because you may be too stressed to give consent immediately, a family member or legal guardian will be asked for permission on your behalf. The medical team will give you repeated doses of the assigned medication(s) as needed, monitor your response closely, and stop treatment if your blood pressure drops too low or other safety concerns arise.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Denmark